Generic Medicines
-
{
- All
- News
- Videos
-
India Can Lead Global Probiotic Movement Using Traditional Diets, Says NITI Aayog's Rajiv Gauba
New Delhi, March 28 (IANS) India's rich heritage of fermented foods should be used to reverse the current shift toward ultra‑processed diets that threaten gut health and long‑term public health, Rajiv Gauba, Member, NITI Aayog, said at a probiotic sy
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India Can Lead Global Probiotic Movement Using Traditional Diets, Says NITI Aayog's Rajiv Gauba
New Delhi, March 28 (IANS) India's rich heritage of fermented foods should be used to reverse the current shift toward ultra‑processed diets that threaten gut health and long‑term public health, Rajiv Gauba, Member, NITI Aayog, said at a probiotic sy
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
How Semaglutide Works: Understanding Appetite, Hormones And Weight Loss In Simple Terms
Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and metabolism.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Pradhan Mantri Jan Aushadhi Pariyojana Expands Access For People In Dumka, Jharkhand
Dumka (Jharkhand), March 19 (IANS) People in Jharkhand's Dumka district are purchasing medicines at affordable rates from a pharmacy centre operating under the Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana, bringing significant relief to poor and u
-
50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026
Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
-
Jan Aushadhi Kendra In Jamtara Provides Affordable Medicines To Poor, Middle-Class People, Drawing Over 200 Patients Daily
The Jan Aushadhi Kendra located near Veer Kunwar Chowk in Jamtara district of Jharkhand, is fast emerging as a major relief for poor and middle-class people, ensuring that affordable and quality medicines reach the general public.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
